Consequently, simultaneous inhibition of FLT3 and p300/CBP led to enhanced suppression of both FLT3 signaling and H3K27 acetylation, resulting in intensified G0/G1 phase cell cycle arrest, thereby demonstrating synergistic effects in AML cell lines and xenograft models. This evidence concerns the gene EP300 and acute myeloid leukemia.